1 Min Read
Feb 15 (Reuters) - PROMORE PHARMA AB:
* WILL ASSUME RESPONSIBILITY FOR MANUFACTURING OF INVESTIGATIONAL MEDICINAL PRODUCT FOR CLINICAL PHASE III TRIAL FOR PXL01 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.